Correction to Lancet Diabetes Endocrinol 2018; 6: 114-21

No authors listed

Published Erratum

No authors listed. Lancet Diabetes Endocrinol. 2019 Apr.

. 2019 Apr;7(4):e4.

doi: 10.1016/S2213-8587(19)30092-0.

No abstract available

Erratum for

Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial.
Ballmann M, Hubert D, Assael BM, Staab D, Hebestreit A, Naehrlich L, Nickolay T, Prinz N, Holl RW; CFRD Study Group. Ballmann M, et al. Lancet Diabetes Endocrinol. 2018 Feb;6(2):114-121. doi: 10.1016/S2213-8587(17)30400-X. Epub 2017 Dec 5. Lancet Diabetes Endocrinol. 2018. PMID: 29199116 Clinical Trial.